Miltenyi Biotec
Miltenyi Biotec home - back to start page
Home ¦ Contact ¦ Ordering ¦ Terms & conditions ¦ Legal notes ¦ Jobs ¦ Forum ¦ Business development ¦ Sitemap
Miltenyi Biotec home - back to start page
Miltenyi Biotec home - back to start page
Miltenyi Biotec
MACS® Cell SeparationMiltenyi BiotecMACS® Cell AnalysisMiltenyi BiotecMACS® Cell CultureMiltenyi BiotecMACSmolecularMiltenyi BiotecClinical ProductsMiltenyi BiotecIndustrial ServicesMiltenyi BiotecMiltenyi BiotecCustomer supportMiltenyi BiotecCompany

Miltenyi Biotec
Baxter products
MACS Cytokines and Growth Factors
MACS® Tools for neuroscience research
Tregs—the complete portfolio
Comprehensive Genomics Services, just send your samples…
MACS eNewsletter
Subscribe to the
MACS eNewsletter
for regular product information via e-mail.
Miltenyi Biotec
μMACS™ Protein A and μMACS™ Protein G MicroBeads
Less than 2 hours—with the unique MACS® Technology, immunopurification takes just 1–2 hours, while conventional immunoprecipitations can last up to one day.

Minimal background—the minimized non-specific binding of MACS MicroBeads and the efficient washing in the column yield highly pure protein.

Convenient—centrifugation or resuspension steps are not required for immunopurification on MACS Columns.

Gentle and versatile—MACS Column Technology gives high yield of target protein, interacting partners, or molecular complexes, for example when used for chromatin-IP (ChIP) or ribosome display.

The easy way of analytical small-scale immunoprecipitation (IP). The extremely small (diameter 50 nm) µMACS™ Protein A or µMACS™ Protein G MicroBeads ensure very rapid reaction kinetics, so that the formation of the labeled immune complex is generally completed in 30 minutes: The target protein is bound by a specific antibody, while µMACS Protein A or µMACS Protein G MicroBeads bind to the Fc region of the specific antibody; thereby, magnetically labeling the immune complex.

As non-specific protein binding of MACS MicroBeads is negligible compared to sepharose or agarose carrier material, time-consuming and yield-reducing pre-absorption steps of conventional IP are not necessary. Next, the immune complex is immobilized in a µ Column placed in the magnetic field of a µMACS or thermoMACS™ Separator.

MACS Column Technology now allows a very gentle but stringent washing of the target protein simply by adding buffers. This convenient procedure is especially advantageous when handling hazardous material such as radioactively labeled proteins.

Sensitive downstream analyses. Finally, the immunopurified protein is eluted in a small volume, while the MicroBeads remain in the column. By eluting with protein sample buffer, the target protein can directly be loaded on an SDS-PAGE gel for protein staining or Western blotting1, 2.

Alternatively, an enzymatic reaction with the immunoprecipitated protein, such as a kinase assay, can be performed in the µ Column. The thermoMACS Separator provides incubation temperatures of 37 °C and 42 °C in the µ Column.
µMACS Protein A and G MicroBeads not only improve standard IP but significantly accelerate the search for interacting proteins3,4. This includes their use for chromatin immunoprecipitation (ChIP)5 or ribosome display6.
The immunopurification can be upscaled 3–5 times by using M Columns in combination with MiniMACS™ or OctoMACS™ Separator.
Columns
μ Columns, upscale in M Columns
 
Figure 1
Working scheme for immunoprecipitation using μMACS™ Protein A or Protein G MicroBeads.
Figure 2
Immunoprecipitation of the SV40 large T antigen from COS cells using μMACS Protein G MicroBeads. Silver stained SDS gel of the cell lysate (L), a protein marker (M), the immunoprecipitated large T antigen (lane 1, indicated by the arrow), an isotype-matched control antibody (2, immunoprecipitation with rat anti-mouse antibody), and a control without antibody (3) are shown.
Figure 3
Detection of biotinylated surface antigens of the B cell line JOK-I following immunoprecipitation. For immunoprecipitation anti-CD22 (HD239, lane 2) or anti-MHC class I (W6/32, 4) antibodies were used. An isotype-matched antibody (1, 3) was used as a control. Following SDS-PAGE and transfer to a membrane, biotinylated proteins were detected using streptavidin-conjugated peroxidase. (Courtesy of Dr. Reinhard Schwartz-Albiez, Heidelberg, Germany.)
Figure 4
Co-immunoprecipitation of Beta-Catenin (BCat): Androgen Receptor was immunoprecipitated from Dihydrotestosterone (DHT)-stimulated (lane 1, 3) or unstimulated LNCaP cells (2, 4) with µMACS Protein G MicroBeads (1, 2) or with Protein A/G agarose beads (lanes 3, 4 ). Western blot (WB) using anti-Beta-Catenin antibody shows Beta-Catenin co-immunoprecipitated with Androgen Receptor. (Courtesy of D. Mulholland, Vancouver, Canada)
Miltenyi Biotec
Customer login
Customer login
Forgot your password?
New customer?
Get more information
My favorites
Your current favorite list is empty.
Products
μMACS Protein A MicroBeads
for 20-40 immunopurifications
Components:
- 2 mL
Download data sheet
130-071-001
Qty:
 

μMACS Protein G MicroBeads
for 20-40 immunopurifications
Components:
- 2 mL
Download data sheet
130-071-101
Qty:
 

μMACS Protein A/G Starting Kit
for 20-40 immunopurifications
Components:
- 1 μMACS Separator
- 20 μ Columns
- 1 MACS MultiStand
- 2 mL μMACS Protein A or 2 mL μMACS Protein G MicroBeads
130-042-601
Qty:
 

Related products
μMACS HA Isolation Kit (#130-091-122)
μMACS c-myc Isolation Kit (#130-091-123)
μMACS His Isolation Kit (#130-091-124)
μMACS GFP Isolation Kit (#130-091-125)
μMACS GST Isolation Kit (#130-091-370)
MACSelectâ„¢ - Transfected Cell Selection Kits
MACS References
1. Birikh et al. (2003) Proc. Natl. Acad. Sci. USA 100: 283-288.[2691]
2. Brown et al. (2003) J. Cell Sci. 116: 693-700.
3. de Goer de Herve et al. (2005) Blood 106: 2806-2814.
4. Fischer et al. (2002) J. Neurosci. 22: 3700-3707.[2239]
5. Frolova et al. (2006) J. Virol. 8: 4122-4134.
6. Gordon et al. (2006) Mol. Endocrinology 20(5): 1073-1089.
7. Kabsch et al. (2002) J. Virol. 76: 12162-12172.
8. Kopp et al. (2006) Mol. Biol. Cell 17: 2811-2823.
9. Linke et al. (2002) J. Cell Sci. 115: 4877-4889.
10. Longin et al. (2001) J. Cell Sci. 114: 2125-2134.[2238]
11. Menon et al. (2006) Blood 107: 2662-2672.
12. Munoz et al. (2003) J. Biol. Chem. 279: 50791-50802.
13. Ossenbuehl et al. (2006) Plant Cell 18: 2236-2246.
14. Soong et al. (2004) J. Clin. Invest. 113: 1482-1489.
15. Suzuki et al. (2002) J. Immunol. 169: 3954-3962.[2371]
16. von Knethen et al. (2007) J. Cell Biol. 176(5): 681-694.[11139]
17. Zhou et al. (2004) J. Biol. Chem. 279: 13506-13513.
18. Mullholland (2003) MACS&more 7: 10-11.
19. Weichhart et al. (2003) Infect. Immun. 71: 4633-4641.[3085]
Miltenyi Biotec
Miltenyi Biotec
© 1999 - 2008 Miltenyi Biotec
Miltenyi Biotec